Showing results (121-130 of 315) with videos related to
Sort By:
Pageof 32
Gynecologic Oncology|May 1, 1988
A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinomaS A Weiner, S Aristizabal, D S Alberts, et al.Cancer Research|February 1, 1993
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cellsN G Shipp, R T Dorr, D S Alberts, et al.Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drugD S Alberts, K S Griffith, G E Goodman, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1996
New carotenoid values for foods improve relationship of food frequency questionnaire intake estimates to plasma valuesC Ritenbaugh, Y M Peng, M Aickin, et al.Cancer Treatment Reports|February 1, 1979
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trialD S Alberts, R D Hilgers, T E Moon, et al.Investigational New Drugs|January 1, 1985
Phase II trial of bisantrene in non-small cell lung cancerT P Miller, F R Ahmann, C Mackel, et al.Cancer Research|April 1, 1985
Disposition of mitoxantrone in cancer patientsD S Alberts, Y M Peng, S Leigh, et al.Analytical and Quantitative Cytology and Histology|March 26, 1998
Nuclear morphometry in solar keratosisP D Bozzo, L C Vaught, D S Alberts, et al.British Journal of Cancer|April 1, 1980
Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administrationY M Peng, D S Alberts, H S Chen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
In vitro degradation of L-phenylalanine mustard (L-PAM)T L Evans, S Y Chang, D S Alberts, et al.Pageof 32